WASHINGTON (dpa-AFX) - Monday, Galderma (GALD), a dermatology-focused company, announced the U.S. launch of ALASTIN Restorative Eye Complex with TriHex+, an enhanced skincare product designed to address signs of aging across the entire eye area.
The formulation targets crow's feet, under-eye puffiness and upper-eyelid fine lines, supporting skin firmness, elasticity and hydration.
In a clinical evaluation of 29 patients, the product showed a 30.13% improvement in crow's feet fine lines, a 33.63% improvement in under-eye puffiness and a 21.62% reduction in upper-eyelid fine lines after 12 weeks.
The product will initially be available in the U.S. through authorized healthcare providers and provider microsites.
On October 23, Galderma's stock closed trading at $220.14 without any movement on the OTC Markets.
Copyright(c) 2026 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
© 2026 AFX News
